Ani Pharmaceuticals Stock Analysis

ANI Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The book value of ANI Pharmaceuticals was presently reported as 20.54. The company has Price/Earnings To Growth (PEG) ratio of 1.06. ANI Pharmaceuticals recorded a loss per share of 1.04. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 18th of July 2013. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota. ANI Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 601 people. For more info on ANI Pharmaceuticals please contact Nikhil Lalwani at 218 634 3500 or go to https://www.anipharmaceuticals.com.

ANI Pharmaceuticals Investment Alerts

ANI Pharmaceuticals Upcoming and Recent Events

ANI Largest EPS Surprises

View All Earnings Estimates

ANI Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

ANI Stock Institutional Investors

Note, although ANI Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ANI Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.4 B.

ANI Profitablity

The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.

Management Efficiency

As of 03/24/2025, Return On Capital Employed is likely to grow to 0.0006, while Return On Tangible Assets are likely to drop (0.03). At this time, ANI Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 03/24/2025, Liabilities And Stockholders Equity is likely to grow to about 1.3 B, while Non Current Liabilities Other is likely to drop slightly above 16.1 M. ANI Pharmaceuticals' management efficiency ratios could be used to measure how well ANI Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of March, ANI Pharmaceuticals shows the Mean Deviation of 1.63, risk adjusted performance of 0.0854, and Semi Deviation of 1.77. ANI Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

ANI Pharmaceuticals Price Movement Analysis

ANI Pharmaceuticals Insider Trading Activities

ANI Pharmaceuticals Outstanding Bonds

ANI Pharmaceuticals Predictive Daily Indicators

ANI Pharmaceuticals Corporate Filings

ANI Pharmaceuticals Forecast Models

ANI Pharmaceuticals' time-series forecasting models are one of many ANI Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ANI Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ANI Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ANI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ANI Pharmaceuticals. By using and applying ANI Stock analysis, traders can create a robust methodology for identifying ANI entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ANI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ANI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ANI Pharmaceuticals stock analysis indicators help investors evaluate how ANI Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ANI Pharmaceuticals shares will generate the highest return on investment. By understating and applying ANI Pharmaceuticals stock analysis, traders can identify ANI Pharmaceuticals position entry and exit signals to maximize returns.

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.